(MedPage Today) — TORONTO — Blood tests for Alzheimer’s disease biomarkers can be used clinically — and can replace expensive brain scans and invasive cerebrospinal fluid (CSF) sampling — as long as they meet strict criteria for sensitivity…
Source link : https://www.medpagetoday.com/meetingcoverage/aaic/116722
Author :
Publish date : 2025-07-29 18:02:00
Copyright for syndicated content belongs to the linked Source.
